查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1662772

2030 年伴同性动物诊断市场预测：按产品类型、动物类型、诊断方法、应用、最终用户和地区进行的全球分析

Companion Animal Diagnostics Market Forecasts to 2030 - Global Analysis By Product Type (Instruments, Reagents & Kits, Consumables, Software, and Other Product Types), Animal Type, Diagnostic Method, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球伴同性动物诊断市场预计在 2024 年将达到 59.2 亿美元，到 2030 年将达到 113.2 亿美元，预测期内的复合年增长率为 11.4%。

伴同性动物诊断是使用各种仪器、测试和方法诊断宠物（包括狗、猫和其他动物）的疾病的过程。该领域的兽医专业人员使用临床化学、分子诊断、免疫诊断、影像技术和实验室测试来帮助早期发现疾病并追踪治疗效果。诊断技术的进步提高了疾病诊断的准确性和有效性，从而可以为伴同性动物提供更好的预防保健和治疗选择。

北美宠物健康保险协会估计，截至 2022年终，国内宠物保险用户数量为 480 万，比 2021 年增加 22%。

动物保健支出增加

宠物拥有量的快速成长，尤其是在已开发国家，正在推动对兽医服务的需求。宠物饲主越来越多地投资于宠物的健康和福利，因为他们将宠物视为家庭的一部分。兽医学和诊断技术（如影像和分子诊断）的改进将提高早期疾病检测的有效性并鼓励人们在预防性治疗上进行支出。此外，宠物慢性疾病的发生率不断上升，以及人们对定期检查益处的认识不断提高，促使饲主愿意为他们的宠物花钱购买医疗和诊断服务。

保险范围限制

有限的诊断成本意味着许多饲主不愿意为他们的动物寻求早期诊断和治疗。这可能会导致严重的延迟检测，从而对您的宠物的健康产生负面影响并最终导致更高的治疗费用。此外，低收入家庭因缺乏全面保险而受到严重影响，限制了他们获得尖端诊断设备和治疗的机会。这限制了市场成长，阻碍了更广泛的兽医诊断方法的发展，可能导致疾病诊断不足、兽医就诊次数减少，最终导致宠物健康恶化。

扩建兽医医院和诊所

随着越来越多兽医医院的建立和最先进的诊断技术的安装，对一流诊断设备和服务的需求将会增加。透过提供更广泛的诊断测试，包括影像、分子诊断和临床化学，这些扩展正在提高宠物护理的品质。规模更大、更专业的兽医诊所也能满足越来越多想要获得快速、彻底预防性护理的饲主的需求。兽医行业的兴起推动了尖端诊断服务和产品的采用，从而带来了诊断解决方案的创新。

缺乏训练有素的专业人员

伴同性动物诊断行业合格人才的短缺严重阻碍了兽医服务的品质和可及性。如果没有足够资格的兽医和实验室专业人员，就很难准确、快速地检测宠物的健康问题，从而导致误诊和延误治疗。这种短缺也会使先进的诊断设备难以有效使用，因为需要熟练的人员来解释结果并操作复杂的设备。此外，缺乏训练有素的人员的地区可能会面临诊断服务价格更高、等待时间更长的问题，从而降低伴同性动物医学的整体有效性，并阻碍尖端诊断工具的采用。

COVID-19 的影响

COVID-19 疫情以多种方式影响了伴同性动物诊断市场。最初，由于人类健康问题和诊所就诊机会有限，封锁和限制措施导致兽医咨询和诊断程序减少。然而，随着疫情期间宠物拥有量激增，对宠物医疗保健的需求也随之增加，增加了对诊断服务的需求。此外，疫情凸显了预防保健的重要性，并导致人们长期转向对宠物进行定期诊断检查。

预计预测期内消耗品部分将成长至最大的部分。

由于需要对宠物进行持续的健康监测以及标准诊断测试的增加，预计预测期内消耗品部分将占据最大的市场占有率。常规诊断程序需要试剂、检测套组和样本收集材料等消耗品。随着兽医医院和诊所扩大其诊断能力，对可靠的一次性耗材的需求不断增加，推动了市场扩张。照护现场诊断的创新也推动了对耗材的需求。

预计预测期内，兽医院部门将以最高的复合年增长率成长。

预计预测期内兽医院部门将呈现最高成长率。随着宠物饲主越来越关注宠物的健康以及宠物拥有率的上升，诊所对诊断服务的需求也增加。这需要这些诊所配备先进的诊断设备和工具。随着宠物保险覆盖范围的扩大以及饲主寻求更全面的治疗（通常包括诊断测试），市场正在扩大。

比最大的地区

由于可支配收入的增加和人们对宠物保健认识的提高，预计亚太地区将在预测期内占据最大的市场占有率。随着兽医基础设施的不断扩大和先进诊断工具的普及，越来越多的饲主希望定期为宠物进行健康检查。这一趋势推动了对诊断服务的需求，刺激了技术创新并刺激了市场扩张，尤其是在中国和印度等国家。

复合年增长率最高的地区

由于宠物拥有率高且对宠物健康和保健的兴趣日益浓厚，预计北美在预测期内的复合年增长率最高。宠物饲主越来越寻求先进的诊断解决方案，推动了对分子诊断和成像工具等最尖端科技的需求。这一趋势导致兽医院和诊所的扩张，从而刺激市场成长。此外，可支配收入的增加也导致宠物医疗保健和诊断支出的增加。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场参与企业（最多 3 家公司）进行全面分析
    • 主要企业的 SWOT 分析（最多 3 家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争性基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第 2 章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二手研究资料资讯来源
    • 先决条件

第三章 市场走势分析

  • 介绍
  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第 4 章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球宠物兽医诊断市场依产品类型划分

  • 介绍
  • 装置
  • 试剂和套件
  • 耗材
  • 软体
  • 其他的

6. 全球宠物诊断市场（依动物类型）

  • 介绍
  • 狗
  • 猫
  • 马
  • 其他的

7. 全球伴侣动物诊断市场（依诊断方法）

  • 介绍
  • 血液学
  • 分子诊断
  • 免疫诊断
  • 临床化学
  • 大便检查
  • 影像学
  • 尿液检查
  • 其他的

第 8 章全球宠物兽医诊断市场（按应用）

  • 介绍
  • 细菌学
  • 病毒学
  • 临床病理学
  • 寄生虫学
  • 其他的

9. 全球宠物兽医诊断市场（按最终用户）

  • 介绍
  • 动物诊所
  • 兽医诊所
  • 就地检验
  • 诊断实验室
  • 科学研究机构和大学
  • 其他的

第 10 章。

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Idexx Laboratories, Inc.
  • Thermo Fisher Scientific, Inc.
  • Heska Corporation
  • Virbac
  • Elanco Animal Health
  • Randox Laboratories
  • Zoetis Inc.
  • Boehringer Ingelheim
  • Medi-Lab
  • VCA Animal Hospitals
  • Neogen Corporation
  • Horizon Veterinary Diagnostics
  • BioNote, Inc.
  • Reflxion
  • Agrolabo SPA
Product Code: SMRC28633

According to Stratistics MRC, the Global Companion Animal Diagnostics Market is accounted for $5.92 billion in 2024 and is expected to reach $11.32 billion by 2030 growing at a CAGR of 11.4% during the forecast period. Companion animal diagnostics is the process of diagnosing illnesses and ailments in pets, including dogs, cats, and other animals, using a variety of instruments, examinations, and methods. Veterinary professionals use clinical chemistry, molecular diagnostics, immunodiagnostics, imaging technologies, and laboratory testing in this sector to assist identify diseases early, track the effectiveness of treatments. Better preventative care and treatment choices for companion animals are made possible by improvements in diagnostics, which increase the precision and effectiveness of ailment diagnosis.

According to the data published by the North American Pet Health Insurance Association Inc., in 2023, the total premium volume for pet insurance in the country was USD 3.2 billion. The total number of pets insured in the country at year-end 2022 was 4.8 million, a 22% increase since 2021.

Market Dynamics:

Driver:

Increase in animal healthcare spending

Veterinary services are in greater demand as a result of the sharp increase in pet ownership, particularly in developed nations. Owners are more inclined to make investments in their pets' health and wellbeing as they are increasingly seen as part of the family. Improvements in veterinary medicine and diagnostic technology, like imaging and molecular diagnostics, increase the efficacy of early disease identification and promote spending on preventative treatment. Pet owners' willingness to spend more money on medical care and diagnostic services for their animals is also encouraged by the growing prevalence of chronic diseases in pets and increased awareness of the advantages of routine checkups.

Restraint:

Limited insurance coverage

Financial limitations for diagnostic procedures can discourage many pet owners from seeking early diagnosis or treatment for their animals. This may result in the delayed identification of severe medical disorders, which could have a detrimental effect on the pet's health and ultimately raise treatment expenses. Additionally, lower-income households are disproportionately impacted by the lack of comprehensive insurance alternatives, which restricts their access to cutting-edge diagnostic equipment and care. This could restrict market growth and impede the development of more widely available veterinary diagnostics, leading to an under diagnosis of diseases, fewer veterinary visits, and ultimately worse health outcomes for pets.

Opportunity:

Expansion of veterinary clinics and hospitals

The demand for top-notch diagnostic equipment and services rises as more veterinary clinics are built and outfitted with cutting-edge diagnostic technologies. By providing a wider range of diagnostic tests, including imaging, molecular diagnostics, and clinical chemistry, these enlarged facilities can improve the quality of pet healthcare. Larger and more specialized veterinary clinics also serve the increasing number of pet owners who want prompt, thorough, and preventative care for their animals. The adoption of cutting-edge diagnostic services and products is fuelled by the rise of the veterinary industry and offers chances for diagnostic solution innovation.

Threat:

Shortage of trained professionals

The quality and accessibility of veterinary services are seriously hampered by the lack of qualified personnel in the companion animal diagnostics industry. It becomes more difficult to detect pet health issues accurately and promptly when there are insufficiently qualified veterinarians and laboratory professionals, which can result in misdiagnosis or delayed treatments. Because skilled personnel are needed to interpret results and operate complicated equipment, this shortage may also make it more difficult to use advanced diagnostic instruments effectively. Furthermore, areas with a shortage of trained personnel may see higher diagnostic service charges and longer wait times, which would lower the overall efficacy of companion animal healthcare and impede the uptake of state-of-the-art diagnostic tools.

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the companion animal diagnostics market. Initially, lockdowns and restrictions led to a decrease in veterinary visits and diagnostic procedures due to concerns about human health and limited access to clinics. However, as pet ownership surged during the pandemic, the demand for pet healthcare increased, fueling the need for diagnostic services. Additionally, the pandemic highlighted the importance of preventive care, leading to a long-term shift toward more routine diagnostic check-ups for pets.

The consumables segment is expected to be the largest during the forecast period

The consumables segment is expected to account for the largest market share during the forecast period, due to the necessity of ongoing pet health monitoring and the rise in standard diagnostic testing. For routine diagnostic procedures, consumables such reagents, test kits, and sample collection materials are necessary. The demand for dependable, disposable consumables increases as veterinary clinics and hospitals broaden their diagnostic capabilities, which fuels market expansion. Innovations in point-of-care diagnostics also increase the demand for consumables.

The veterinary clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate. Clinics witness an increase in demand for diagnostic services as pet owners become more involved in the health of their animals and pet ownership rises. This makes sophisticated diagnostic equipment and tools necessary in these clinics. The market is growing because pet owners are encouraged to seek more thorough treatment, which frequently includes diagnostic testing, by the increase in pet insurance coverage.

Region with largest share:

During the forecast period, Asia Pacific region is expected to hold the largest market share, due to rising disposable incomes, and improving awareness of pet healthcare. With expanding veterinary infrastructure and greater access to advanced diagnostic tools, more pet owners are seeking regular health check-ups for their animals. This trend is driving demand for diagnostic services, fostering innovation, and encouraging market expansion, particularly in countries like China and India.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to high pet ownership and a strong focus on pet health and wellness. Pet owners are increasingly seeking advanced diagnostic solutions, driving demand for cutting-edge technologies like molecular diagnostics and imaging tools. This trend has led to the expansion of veterinary clinics and hospitals, encouraging growth in the market. Additionally, rising disposable incomes contribute to increase spending on pet healthcare and diagnostics.

Key players in the market

Some of the key players profiled in the Companion Animal Diagnostics Market include Idexx Laboratories, Inc., Thermo Fisher Scientific, Inc., Heska Corporation, Virbac, Elanco Animal Health, Randox Laboratories, Zoetis Inc., Boehringer Ingelheim, Medi-Lab, VCA Animal Hospitals, Neogen Corporation, Horizon Veterinary Diagnostics, BioNote, Inc., Reflxion, and Agrolabo S.P.A.

Key Developments:

In December 2024, Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the GibcoCTS(TM) Detachable Dynabeads(TM) CD4 and CTS Detachable Dynabeads CD8. These latest products expand on Thermo Fisher's CTS Detachable Dynabeads platform, which represents a new generation of cell therapy isolation and/or activation products that prioritize cell quality while also creating greater workflow control.

In December 2024, IDEXX Laboratories, Inc. announced that the Company's Board of Directors authorized an increase in its ongoing share repurchase program, authorizing the repurchase of up to five million additional shares of the Company's common stock. Repurchases may be made at management's discretion from time to time in the open market or in negotiated transactions.

Product Types Covered:

  • Instruments
  • Reagents & Kits
  • Consumables
  • Software
  • Other Product Types

Animal Types Covered:

  • Dogs
  • Cats
  • Horses
  • Other Animal Types

Diagnostic Methods Covered:

  • Hematology
  • Molecular Diagnostics
  • Immunodiagnostics
  • Clinical Chemistry
  • Fecal Testing
  • Imaging
  • Urinalysis
  • Other Methods

Applications Covered:

  • Bacteriology
  • Virology
  • Clinical Pathology
  • Parasitology
  • Other Applications

End Users Covered:

  • Veterinary Clinics
  • Veterinary Hospitals
  • Point-of-care Testing
  • Diagnostic Laboratories
  • Research Institutes and Universities
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Companion Animal Diagnostics Market, By Product Type

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Reagents & Kits
  • 5.4 Consumables
  • 5.5 Software
  • 5.6 Other Product Types

6 Global Companion Animal Diagnostics Market, By Animal Type

  • 6.1 Introduction
  • 6.2 Dogs
  • 6.3 Cats
  • 6.4 Horses
  • 6.5 Other Animal Types

7 Global Companion Animal Diagnostics Market, By Diagnostic Method

  • 7.1 Introduction
  • 7.2 Hematology
  • 7.3 Molecular Diagnostics
  • 7.4 Immunodiagnostics
  • 7.5 Clinical Chemistry
  • 7.6 Fecal Testing
  • 7.7 Imaging
  • 7.8 Urinalysis
  • 7.9 Other Methods

8 Global Companion Animal Diagnostics Market, By Application

  • 8.1 Introduction
  • 8.2 Bacteriology
  • 8.3 Virology
  • 8.4 Clinical Pathology
  • 8.5 Parasitology
  • 8.6 Other Applications

9 Global Companion Animal Diagnostics Market, By End User

  • 9.1 Introduction
  • 9.2 Veterinary Clinics
  • 9.3 Veterinary Hospitals
  • 9.4 Point-of-care Testing
  • 9.5 Diagnostic Laboratories
  • 9.6 Research Institutes and Universities
  • 9.7 Other End Users

10 Global Companion Animal Diagnostics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Idexx Laboratories, Inc.
  • 12.2 Thermo Fisher Scientific, Inc.
  • 12.3 Heska Corporation
  • 12.4 Virbac
  • 12.5 Elanco Animal Health
  • 12.6 Randox Laboratories
  • 12.7 Zoetis Inc.
  • 12.8 Boehringer Ingelheim
  • 12.9 Medi-Lab
  • 12.10 VCA Animal Hospitals
  • 12.11 Neogen Corporation
  • 12.12 Horizon Veterinary Diagnostics
  • 12.13 BioNote, Inc.
  • 12.14 Reflxion
  • 12.15 Agrolabo S.P.A.

List of Tables

  • Table 1 Global Companion Animal Diagnostics Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Companion Animal Diagnostics Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Companion Animal Diagnostics Market Outlook, By Instruments (2022-2030) ($MN)
  • Table 4 Global Companion Animal Diagnostics Market Outlook, By Reagents & Kits (2022-2030) ($MN)
  • Table 5 Global Companion Animal Diagnostics Market Outlook, By Consumables (2022-2030) ($MN)
  • Table 6 Global Companion Animal Diagnostics Market Outlook, By Software (2022-2030) ($MN)
  • Table 7 Global Companion Animal Diagnostics Market Outlook, By Other Product Types (2022-2030) ($MN)
  • Table 8 Global Companion Animal Diagnostics Market Outlook, By Animal Type (2022-2030) ($MN)
  • Table 9 Global Companion Animal Diagnostics Market Outlook, By Dogs (2022-2030) ($MN)
  • Table 10 Global Companion Animal Diagnostics Market Outlook, By Cats (2022-2030) ($MN)
  • Table 11 Global Companion Animal Diagnostics Market Outlook, By Horses (2022-2030) ($MN)
  • Table 12 Global Companion Animal Diagnostics Market Outlook, By Other Animal Types (2022-2030) ($MN)
  • Table 13 Global Companion Animal Diagnostics Market Outlook, By Diagnostic Method (2022-2030) ($MN)
  • Table 14 Global Companion Animal Diagnostics Market Outlook, By Hematology (2022-2030) ($MN)
  • Table 15 Global Companion Animal Diagnostics Market Outlook, By Molecular Diagnostics (2022-2030) ($MN)
  • Table 16 Global Companion Animal Diagnostics Market Outlook, By Immunodiagnostics (2022-2030) ($MN)
  • Table 17 Global Companion Animal Diagnostics Market Outlook, By Clinical Chemistry (2022-2030) ($MN)
  • Table 18 Global Companion Animal Diagnostics Market Outlook, By Fecal Testing (2022-2030) ($MN)
  • Table 19 Global Companion Animal Diagnostics Market Outlook, By Imaging (2022-2030) ($MN)
  • Table 20 Global Companion Animal Diagnostics Market Outlook, By Urinalysis (2022-2030) ($MN)
  • Table 21 Global Companion Animal Diagnostics Market Outlook, By Other Methods (2022-2030) ($MN)
  • Table 22 Global Companion Animal Diagnostics Market Outlook, By Application (2022-2030) ($MN)
  • Table 23 Global Companion Animal Diagnostics Market Outlook, By Bacteriology (2022-2030) ($MN)
  • Table 24 Global Companion Animal Diagnostics Market Outlook, By Virology (2022-2030) ($MN)
  • Table 25 Global Companion Animal Diagnostics Market Outlook, By Clinical Pathology (2022-2030) ($MN)
  • Table 26 Global Companion Animal Diagnostics Market Outlook, By Parasitology (2022-2030) ($MN)
  • Table 27 Global Companion Animal Diagnostics Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 28 Global Companion Animal Diagnostics Market Outlook, By End User (2022-2030) ($MN)
  • Table 29 Global Companion Animal Diagnostics Market Outlook, By Veterinary Clinics (2022-2030) ($MN)
  • Table 30 Global Companion Animal Diagnostics Market Outlook, By Veterinary Hospitals (2022-2030) ($MN)
  • Table 31 Global Companion Animal Diagnostics Market Outlook, By Point-of-care Testing (2022-2030) ($MN)
  • Table 32 Global Companion Animal Diagnostics Market Outlook, By Diagnostic Laboratories (2022-2030) ($MN)
  • Table 33 Global Companion Animal Diagnostics Market Outlook, By Research Institutes and Universities (2022-2030) ($MN)
  • Table 34 Global Companion Animal Diagnostics Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.